You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 6, June 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatology, Other
 •Alert me on articles by topic

Management of Merkel Cell Carcinoma

What We Know

Arch Dermatol. 2006;142:771-774.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Merkel cell carcinoma is a growing health problem and the second most common cause of nonmelanoma skin cancer death. A recent review of the population-based cancer-related death registry (1994-1998) in the state of Western Australia detected 120 deaths from nonmelanoma skin cancer, including 89 from squamous cell carcinoma and 22 from Merkel cell carcinoma.1 Incidence of Merkel cell carcinoma appears to be increasing, with the rate detected by the Surveillance, Epidemiology, and End Results (SEER) registry rising 3-fold from an age-adjusted rate of 0.15 cases per 100 000 in 1986 to 0.44 per 100 000 in 2001.2 The estimated annual percentage change in incidence during this period was 8% per year for Merkel cell compared with 3% per year for melanoma. Factors contributing to the rise may include a higher concurrent risk of suppressed immunity, such as that associated with organ transplantation, and the share of the population represented by elderly persons, . . . [Full Text of this Article]


AUTHOR INFORMATION
Murad Alam, MD


RELATED ARTICLES

Sentinel Lymph Node Biopsy for Evaluation and Treatment of Patients With Merkel Cell Carcinoma: The Dana-Farber Experience and Meta-analysis of the Literature
Sheela G. Gupta, Linda C. Wang, Pablo F. Peñas, Martina Gellenthin, Stephanie J. Lee, and Paul Nghiem
Arch Dermatol. 2006;142(6):685-690.
ABSTRACT | FULL TEXT  

Adjuvant Local Irradiation for Merkel Cell Carcinoma
Kevan G. Lewis, Martin A. Weinstock, Amy L. Weaver, and Clark C. Otley
Arch Dermatol. 2006;142(6):693-700.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Merkel Cell Carcinoma As a Solitary Metastasis to the Testis
Whitman et al.
JCO 2007;25:3785-3786.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.